[HTML][HTML] Hyperuricemia-related diseases and xanthine oxidoreductase (XOR) inhibitors: an overview
C Chen, JM Lü, Q Yao - Medical science monitor: international …, 2016 - ncbi.nlm.nih.gov
Uric acid is the final oxidation product of purine metabolism in humans. Xanthine
oxidoreductase (XOR) catalyzes oxidative hydroxylation of hypoxanthine to xanthine to uric …
oxidoreductase (XOR) catalyzes oxidative hydroxylation of hypoxanthine to xanthine to uric …
HLA association with drug‐induced adverse reactions
Adverse drug reactions (ADRs) remain a common and major problem in healthcare. Severe
cutaneous adverse drug reactions (SCARs), such as Stevens–Johnson syndrome …
cutaneous adverse drug reactions (SCARs), such as Stevens–Johnson syndrome …
2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to …
Gout is a disorder that manifests as a spectrum of clinical and pathologic features built on a
foundation of an excess body burden of uric acid, manifested in part by hyperuricemia …
foundation of an excess body burden of uric acid, manifested in part by hyperuricemia …
Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the …
A Qaseem, TJ Wilt, R Rich, LL Humphrey… - Annals of internal …, 2017 - acpjournals.org
This article has been corrected. The original version (PDF) is appended to this article as a
Supplement. Description: The American College of Physicians (ACP) and the American …
Supplement. Description: The American College of Physicians (ACP) and the American …
Management of acute and recurrent gout: a clinical practice guideline from the American College of Physicians
A Qaseem, RP Harris, MA Forciea… - Annals of internal …, 2017 - acpjournals.org
Description: The American College of Physicians (ACP) developed this guideline to present
the evidence and provide clinical recommendations on the management of gout. Methods …
the evidence and provide clinical recommendations on the management of gout. Methods …
Allopurinol hypersensitivity: investigating the cause and minimizing the risk
LK Stamp, RO Day, J Yun - Nature Reviews Rheumatology, 2016 - nature.com
Allopurinol is the most commonly prescribed urate-lowering therapy for the management of
gout. Serious adverse reactions associated with allopurinol, while rare, are feared owing to …
gout. Serious adverse reactions associated with allopurinol, while rare, are feared owing to …
A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
Human leukocyte antigen (HLA) encoded by the HLA gene is an important modulator for
immune responses and drug hypersensitivity reactions as well. Genetic polymorphisms of …
immune responses and drug hypersensitivity reactions as well. Genetic polymorphisms of …
Allopurinol use and risk of fatal hypersensitivity reactions: a nationwide population-based study in Taiwan
CY Yang, CH Chen, ST Deng, CS Huang… - JAMA internal …, 2015 - jamanetwork.com
Importance Allopurinol, a first-line drug used for treating gout, is increasingly prescribed
worldwide to patients with asymptomatic hyperuricemia and comorbid renal or …
worldwide to patients with asymptomatic hyperuricemia and comorbid renal or …
Controversies in drug allergy: in vitro testing
C Mayorga, DG Ebo, DM Lang, WJ Pichler… - Journal of Allergy and …, 2019 - Elsevier
Despite their low frequency, drug hypersensitivity reactions (DHRs) can be serious and
result in lifelong sequelae. The diagnosis is critical to avert future reactions and should …
result in lifelong sequelae. The diagnosis is critical to avert future reactions and should …
Allopurinol hypersensitivity: a systematic review of all published cases, 1950–2012
SN Ramasamy, CS Korb-Wells, DRW Kannangara… - Drug safety, 2013 - Springer
Background Allopurinol is the primary therapy for the management of chronic gout.
Utilization of allopurinol has increased in tandem with the growing prevalence of gout …
Utilization of allopurinol has increased in tandem with the growing prevalence of gout …